579 related articles for article (PubMed ID: 22580334)
1. Nanoparticles in drug delivery: past, present and future.
Couvreur P
Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
3. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
4. Targeting of injectable drug nanocrystals.
Fuhrmann K; Gauthier MA; Leroux JC
Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
[TBL] [Abstract][Full Text] [Related]
5. Physical and chemical stability of drug nanoparticles.
Wu L; Zhang J; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
7. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles.
Labouta HI; Kraus T; El-Khordagui LK; Schneider M
Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347
[TBL] [Abstract][Full Text] [Related]
8. Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges.
Liu-Snyder P; Webster TJ
Expert Rev Med Devices; 2006 Nov; 3(6):683-7. PubMed ID: 17280531
[No Abstract] [Full Text] [Related]
9. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
10. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
12. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
13. Controlling drug nanoparticle formation by rapid precipitation.
D'Addio SM; Prud'homme RK
Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
[TBL] [Abstract][Full Text] [Related]
14. Approaches towards enhanced transepithelial drug delivery.
Majumdar S; Mitra AK
Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles and microparticles for skin drug delivery.
Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
[TBL] [Abstract][Full Text] [Related]
16. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
18. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
Baker JR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
[TBL] [Abstract][Full Text] [Related]
19. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
20. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
